Back to search
FDAFDA · Food and drugs·Recall number D-1047-2016

Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada

Published June 29, 2016 · Recall initiated: May 18, 2016

Summary

FDA records drug Class III recall D-1047-2016, published June 29, 2016 and initiated May 18, 2016. Recalling firm: Attix Pharmaceuticals Inc; Status: Terminated; Reported quantity: N/A; Lot: Lot Number: A3160A, Manufacturer batch number: 151201, Expiry November 2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Attix Pharmaceuticals Inc
Distributor
CO
Lot
Lot Number: A3160A, Manufacturer batch number: 151201, Expiry November 2017
Risk classification
Class III
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada recalled?

Yes. FDA published recall D-1047-2016 on June 29, 2016. Reported hazard: cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration

What should I do if I have this product?

Voluntary: Firm initiated · Telephone